S
Saama develops life science solutions that accelerate the delivery of therapies to patients. With innovative AI technologies, Saama drives breakthrough intelligence into clinical and commercial operations. The Saama platform powered the clinical trial that led to the world’s first COVID-19 vaccine. Headquartered in Campbell, CA, with employees around the globe, Saama is committed to helping customers save and improve lives. Discover more at saama.com.
Investor insights
Funding rounds participated in
$40M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Software Development
Sectors
Software Development
Funding rounds raised
Total raised
$40M
from investors over 1 rounds
S
Saama raised $40M on April 25, 2019